5Fluorouracil Clinical Trials

4 actively recruiting trials across 2 locations

No change since May 2026

Also known as: 5-FU, Fluorouracil Accord, Fluorouracil Tevo

Pipeline

Phase 2: 2Phase 3: 1Phase 1/2: 1

Top Sponsors

Uppsala University1
Rutgers, The State University of New Jersey1
I-Mab Biopharma US Limited1
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano1

Indications

Cancer4
Gastroesophageal Junction Carcinoma1
Peritoneal Metastases1
Advanced Cancer1
Esophageal Adenocarcinoma1

Other2 trials

5FU/LV, Irinotecan, Temozolomide and Bevacizumab for MGMT Silenced, Microsatellite Stable Metastatic Colorectal Cancer.

Phase 1/2

Efficacy of Hyperthermic Intraperitoneal Chemotherapy

Phase 3

Goodyear, Arizona1 trial

Givastomig Combined With Nivolumab and Chemotherapy in Adults With CLDN18.2 Positive Metastatic Gastric Cancer (GIVA-2)

I-Mab Site 1016

Phase 2

Elizabeth, New Jersey1 trial

ATATcH Alternating Treatment Plans for Advanced Cancer

Trinitas Hospital and Comprehensive Cancer Center

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.